News

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...
NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA ...
University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.
The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
The cell creates mRNA, a copy of DNA, to assemble proteins. The mRNA is then read by a different molecule known as a ribosome ...
Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.
Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...